Screener
Kiniksa Pharmaceuticals International, plc KNSA Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Kiniksa Pharmaceuticals International, plc in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Kiniksa Pharmaceuticals International, plc’s 10-Q, filed July 28, 2026.
- Filed
- Jul 28, 2026, 4:17 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001104659-26-087545
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Accounts receivable, net | 23,490 | 15,594 |
| Inventory | 70,930 | 54,895 |
| Prepaid expenses and other current assets | 48,285 | 42,614 |
| Total current assets | 668,633 | 527,177 |
| Property and equipment, net | 2,575 | 1,943 |
| Operating lease right-of-use assets | 8,353 | 9,807 |
| Other long-term assets | 10,834 | 11,307 |
| Intangible asset, net | 14,750 | 15,250 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Kiniksa Pharmaceuticals International, plc's total current assets?
- Kiniksa Pharmaceuticals International, plc (KNSA) reported total current assets of $668.63M in Q2 2026.
- How has Kiniksa Pharmaceuticals International, plc's total current assets changed year-over-year?
- Kiniksa Pharmaceuticals International, plc's total current assets increased by 59.1% year-over-year, from $420.31M to $668.63M.
- What is the long-term trend for Kiniksa Pharmaceuticals International, plc's total current assets?
- Over 5 years (2020 to 2025), Kiniksa Pharmaceuticals International, plc's total current assets has grown at a 9.6% compound annual growth rate (CAGR), from $333.25M to $527.18M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Kiniksa Pharmaceuticals International, plc's total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude